The Immunology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.

1. Immunology Deals and Alliances of 2014
The Immunology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements
entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all
the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.
Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments
Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as
well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the
contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative
R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where
available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of
technologies and products during 2014.
table Of Content
executive Summary
introduction
chapter 1 – Trends In Dealmaking During 2014
1.1 Introduction
1.2. Partnering By Deal Type
1.3. Partnering By Industry Sector
1.4. Partnering By Stage Of Development
1.5. Partnering By Technology Type
1.6. Partnering By Therapy Area
chapter 2 – Average Financial Deal Terms
2.1 Partnering Deals With Headline Values
2.2 Partnering Deals With Upfront Payments
2.3 Partnering Deals With Milestone Payments
2.4 Partnering Deals Withroyalty Rates
chapter 3 – Leading Deals During 2014
3.1. Introduction
3.2. Most Active Dealmakers
3.3. Top Deals By Value During 2014
3.4. Big Pharma Dealmaking Activity
3.5. Big Biotech Dealmaking Activity
chapter 4 – Partnering Deals Directory 2014
4.1. Introduction
4.2. Company A-z
4.3. By Deal Type
4.4. By Stage Of Development
4.5. By Technology Type
4.6. By Therapy Area
about Wildwood Ventures
current Partnering
current Agreements
Immunology Deals and Alliances of 2014

2. ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Immunology Deals and Alliances of 2014